Chancellor’s Council honors pharmacy researcher

Richard D. Leff, Pharm.D., with TTU System Chancellor Robert L. Duncan

Richard D. Leff, Pharm.D., with TTU System Chancellor Robert L. Duncan

Richard D. Leff, Pharm.D., a professor for TTUHSC’s Department of Pharmacy Practice in Dallas and senior associate dean for the School of Pharmacy’s clinical and translational research, is among four TTUHSC faculty members to receive a Chancellor’s Council Distinguished Faculty Award Feb. 10 in Lubbock.

The Chancellor’s Council Distinguished Faculty Award is the Texas Tech University System’s highest faculty honor.

Leff , who received a Distinguished Research Award, came to TTUHSC in 2002 as regional dean for the School of Pharmacy’s Dallas/Fort Worth campus, a position he held until 2013 when he was named the school’s senior associate dean for clinical and translational research. He earned his Pharm.D. degree from the University of Minnesota and completed a postdoctoral fellowship in pediatric pharmacology at the University of Iowa.

Prior to his arrival at TTUHSC, Leff served on the faculties of the University of Texas at Austin, the University of Iowa and the University of Kansas. He has also served as vice president clinical services and research with Child Health Corporation of America and as director of pharmaceutical product development at the Midwest Research Institute. In addition, he founded Pediatric Research Associates, L.L.C., a consulting group formed to address issues related to the Pediatric Research Equity Act.

In his current role, Leff is responsible for strengthening the clinical research infrastructure among the School of Pharmacy regional campuses and promoting institutional collaborations to facilitate faculty scholarship. He is also the founding director of the Clinical Pharmacology & Experimental Therapeutics Center, a designated Center for Research Excellence at the School of Pharmacy. In 2012, Leff was awarded the James A. ‘Buddy’ Davidson Endowed Professorship in Pediatric Pharmacology.

Leff has more than 150 publications to his credit. He is internationally recognized for his experience with drug and medical device development in infants and children and he has been invited to deliver more than 250 presentations. He currently receives research funding from the Cancer Prevention and Research Institute of Texas and the National Institutes of Health Clinical and Translational Science Award.

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories

Health

Texas Tech Physicians Multispecialty Clinic to Open in South Lubbock

The Texas Tech Physicians Multispecialty Clinic will be home to eight clinical services including cardiology, endocrinology, family medicine, internal medicine, orthopaedics (sports medicine), psychiatry, surgery and urology.

Education

TTUHSC Pioneers New Pathway for Pharmacy Education

The TTUHSC Jerry H. Hodge School of Pharmacy is positioning itself for the future with the announcement of its new Pioneer Pathway, an innovative educational pathway that will leverage hybrid learning strategies.

Education

The Texas Tech University Health Sciences Center Master of Public Health Program Awarded Seven-Year Accreditation

The MPH program at the TTUHSC Julia Jones Matthews School of Population and Public Health has been awarded seven-year accreditation by the Council on Education for Public Health (CEPH) through July 1, 2031.